Bio Substitution Plan Would Put Germany On ‘Wrong Track’

 
• By Aidan Fry

Plans for substituting biological drugs at pharmacy level that have been passed by Germany’s lower house of parliament threaten to undo the good work done to date in winning trust in biosimilars, local industry association Pro Biosimilars fears.

Wrong way
Germany is heading down the wrong path by planning to allow pharmacists to substitute biologic drugs, local industry feels • Source: Shutterstock

More from Biosimilars

More from Products